Patent · US Active

Bivalent, bispecific antibodies

US10138293B2 · kind B2 · utility

5Cited by

43References

12Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Christian Klein · Iffeldorf, DE
Wolfgang Schaefer · Sankt Augustin, DE

Key dates

Filing date	Jan 31, 2012
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Feb 16, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to nucleic acids which encode the heavy chains and light chains of a novel domain exchanged, bivalent, bispecific antibody, and vectors comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.